Q3 2025 Earnings Call Transcript February 13, 2025 Operator: And good day. Thank you for standing by. Welcome to VistaGen ...
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...
Hosted on MSN16h
A Popular Breakfast Brand’s Recall Has Been Updated To the FDA’s Highest Risk LevelThere are two noteworthy updates from a notice issued late this week on what the FDA says could cause serious illness or ...
TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company ...
The Municipality of Huron Shores is still awaiting the results of a detailed inspection of the historic Dean Lake Bridge, ...
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback